Erudio Healtherudio.com
Drug
Botensilimab trials: what clinicians said in public
An HCP commentary report on 1 clinical trial studying botensilimab: NEST3. It covers what clinicians said in public about one trial, on podcasts, videos and posts, every statement linked to its source. Below them, 5 more trials with public commentary and no report yet.
| Trial | Indication | Phase | Statements | Sources | Size | Checked | Preview |
|---|---|---|---|---|---|---|---|
| NEST3 NCT07595874 · City of Hope Medical Center | advanced resectable colorectal cancer | Phase 2 | 127 | 23 | Focused | Oct 29, 2026 | Preview |
| No report yetTrials with public commentary we haven't built a report for. Size is an estimate of the verified statements the commentary we've indexed so far will yield; final coverage is set when we build the report, within 24 hours of your confirmed order. You never pay more than quoted: a report delivered at a smaller size costs that size's price. Some can also be requested as a free preview. | |||||||
| NEST-1 NCT05571293 · Weill Medical College of Cornell University DeepView → | resectable colorectal cancer | Phase 2 | Deep | View | |||
| NCT05630183 NCT05630183 · Agenus Inc. StandardView → | metastatic pancreatic ductal adenocarcinoma after prior FOLFIRINOX | Phase 2 | Standard | View | |||
| BBOpCo NCT06268015 · Nicholas DeVito, MD FocusedView → | first-line microsatellite stable metastatic colorectal cancer | Phase 2 | Focused | View | |||
| NCT03860272 NCT03860272 · Agenus Inc. FocusedView → | advanced cancer | Phase 1 | Focused | View | |||
| NCT05608044 NCT05608044 · Agenus Inc. FocusedView → | Not given | Phase 2 | Focused | View | |||